FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109335217> ?p ?o ?g. }

• W2109335217 endingPage "1404" @default.
• W2109335217 startingPage "1395" @default.
• W2109335217 abstract "Recent data suggest that the phosphatidylinositol 3-kinase (PI3-K)/Akt/mammalian target of rapamycin (mTOR) pathway is important in diabetic nephropathy. The effect of mTOR blockade by sirolimus (SRL) in diabetic kidney disease in rats was investigated. Diabetes was induced by streptozotocin in male Sprague-Dawley rats. Sixteen weeks later, diabetic animals were divided into the following groups: diabetes (D; n = 8), diabetes + SRL at 1 mg/kg per d, SRL trough level 2.3 +/- 0.25 ng/ml (D+SRL; n = 7); and diabetes + normoglycemia maintained by insulin implants (D+NG; n = 5). There was an age-matched nondiabetic group (ND; n = 6). All animals were followed for 4 wk. The D group showed glomerular hypertrophy (mean glomerular volume 5.0 +/- 0.4 in D versus 3.3 +/- 0.2 10(6) mu(3) in ND; P < 0.05) without renal hyperplasia (calculated by reverse transcription-PCR of proliferative cell nuclear antigen) and albuminuria (29 +/- 4 in D versus 1.4 +/- 1.5 mg/24 h in ND; P < 0.05). Both D+NG and D+SRL groups had a significant reduction of albuminuria, although glomerular hypertrophy was still present. SRL treatment did not modify the number of infiltrating renal ED1(+) cells. Diabetic animals had greater expression of p-Akt and mTOR, unlike ND rats. NG and SRL treatment reduced p-Akt and normalized mTOR. It is interesting that D+SRL was associated with a significant reduction of renal TGF-beta1 and glomerular connective tissue growth factor. SRL treatment reduced glomerular alpha-smooth muscle actin overexpression and reduced significantly the mesangial matrix accumulation that is characteristic of diabetic nephropathy. In conclusion, mTOR blockade by low-dose SRL has a beneficial effect in diabetic kidney disease, suggesting that the mTOR pathway has an important pathogenic role in diabetic nephropathy." @default.
• W2109335217 created "2016-06-24" @default.
• W2109335217 creator A5003826728 @default.
• W2109335217 creator A5005143724 @default.
• W2109335217 creator A5023390869 @default.
• W2109335217 creator A5039534200 @default.
• W2109335217 creator A5047438099 @default.
• W2109335217 creator A5050633398 @default.
• W2109335217 creator A5064151958 @default.
• W2109335217 creator A5066077591 @default.
• W2109335217 creator A5088500660 @default.
• W2109335217 date "2006-05-01" @default.
• W2109335217 modified "2023-10-16" @default.
• W2109335217 title "Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats" @default.
• W2109335217 cites W1968446955 @default.
• W2109335217 cites W1974873639 @default.
• W2109335217 cites W1987430295 @default.
• W2109335217 cites W1994887713 @default.
• W2109335217 cites W2000519471 @default.
• W2109335217 cites W2002449810 @default.
• W2109335217 cites W2010384231 @default.
• W2109335217 cites W2011409573 @default.
• W2109335217 cites W2011610612 @default.
• W2109335217 cites W2030127399 @default.
• W2109335217 cites W2033569776 @default.
• W2109335217 cites W2033842398 @default.
• W2109335217 cites W2041766504 @default.
• W2109335217 cites W2042065946 @default.
• W2109335217 cites W2059333451 @default.
• W2109335217 cites W2065906356 @default.
• W2109335217 cites W2066334316 @default.
• W2109335217 cites W2106005629 @default.
• W2109335217 cites W2107674876 @default.
• W2109335217 cites W2107904102 @default.
• W2109335217 cites W2108918698 @default.
• W2109335217 cites W2116893045 @default.
• W2109335217 cites W2122712691 @default.
• W2109335217 cites W2122981222 @default.
• W2109335217 cites W2126439225 @default.
• W2109335217 cites W2134936986 @default.
• W2109335217 cites W2136598700 @default.
• W2109335217 cites W2147786790 @default.
• W2109335217 cites W2148184356 @default.
• W2109335217 cites W2154820433 @default.
• W2109335217 cites W2158550605 @default.
• W2109335217 cites W2274413769 @default.
• W2109335217 cites W2417341920 @default.
• W2109335217 cites W4241356386 @default.
• W2109335217 doi "https://doi.org/10.1681/asn.2005050549" @default.
• W2109335217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16597691" @default.
• W2109335217 hasPublicationYear "2006" @default.
• W2109335217 type Work @default.
• W2109335217 sameAs 2109335217 @default.
• W2109335217 citedByCount "226" @default.
• W2109335217 countsByYear W21093352172012 @default.
• W2109335217 countsByYear W21093352172013 @default.
• W2109335217 countsByYear W21093352172014 @default.
• W2109335217 countsByYear W21093352172015 @default.
• W2109335217 countsByYear W21093352172016 @default.
• W2109335217 countsByYear W21093352172017 @default.
• W2109335217 countsByYear W21093352172018 @default.
• W2109335217 countsByYear W21093352172019 @default.
• W2109335217 countsByYear W21093352172020 @default.
• W2109335217 countsByYear W21093352172021 @default.
• W2109335217 countsByYear W21093352172022 @default.
• W2109335217 countsByYear W21093352172023 @default.
• W2109335217 crossrefType "journal-article" @default.
• W2109335217 hasAuthorship W2109335217A5003826728 @default.
• W2109335217 hasAuthorship W2109335217A5005143724 @default.
• W2109335217 hasAuthorship W2109335217A5023390869 @default.
• W2109335217 hasAuthorship W2109335217A5039534200 @default.
• W2109335217 hasAuthorship W2109335217A5047438099 @default.
• W2109335217 hasAuthorship W2109335217A5050633398 @default.
• W2109335217 hasAuthorship W2109335217A5064151958 @default.
• W2109335217 hasAuthorship W2109335217A5066077591 @default.
• W2109335217 hasAuthorship W2109335217A5088500660 @default.
• W2109335217 hasBestOaLocation W21093352171 @default.
• W2109335217 hasConcept C126322002 @default.
• W2109335217 hasConcept C134018914 @default.
• W2109335217 hasConcept C190283241 @default.
• W2109335217 hasConcept C2776174234 @default.
• W2109335217 hasConcept C2777921159 @default.
• W2109335217 hasConcept C2778653478 @default.
• W2109335217 hasConcept C2779280383 @default.
• W2109335217 hasConcept C2779922275 @default.
• W2109335217 hasConcept C2780091579 @default.
• W2109335217 hasConcept C2909763481 @default.
• W2109335217 hasConcept C55493867 @default.
• W2109335217 hasConcept C555293320 @default.
• W2109335217 hasConcept C71924100 @default.
• W2109335217 hasConcept C75217442 @default.
• W2109335217 hasConcept C86554907 @default.
• W2109335217 hasConcept C86803240 @default.
• W2109335217 hasConceptScore W2109335217C126322002 @default.
• W2109335217 hasConceptScore W2109335217C134018914 @default.
• W2109335217 hasConceptScore W2109335217C190283241 @default.
• W2109335217 hasConceptScore W2109335217C2776174234 @default.
• W2109335217 hasConceptScore W2109335217C2777921159 @default.

• next